Xenon Pharmaceuticals Inc (XENE) is a publicly traded Healthcare sector company. As of July 30, 2026, XENE trades at $64.24 with a market cap of $6.10B and a P/E ratio of -14.64. XENE moved +1.84% today. Year to date, XENE is +44.28%; over the trailing twelve months it is +108.61%. Its 52-week range spans $26.74 to $72.66. Analyst consensus is strong buy with an average price target of $75.77. Rallies surfaces XENE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for XENE, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $64.24 |
| Market Cap | $6.10B |
| P/E Ratio | -14.64 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $72.66 |
| 52-Week Low | $26.74 |
| Volume | 417.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.50M |
| Net Income | $-345.91M |
| Gross Margin | 0.00% |
11 analysts cover XENE: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $75.77.